SCHEMBL305714

SCHEMBL305714

COS(=O)(=O)[O-].Cn1cc[n+](C)c1

nearest known ligand 0.33

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.33
NPSR1 Q6W5P4 3/20 0.33
MAPT P10636 2/20 0.33
TP53 P04637 1/20 0.33
THRB P10828 1/20 0.33
RECQL P46063 1/20 0.33
BLM P54132 1/20 0.33
ATM Q13315 1/20 0.33
PSMD14 O00487 1/20 0.31
RAD52 P43351 1/20 0.31
TERT O14746 1/20 0.30
MEN1 O00255 1/20 0.30
APAF1 O14727 1/20 0.30
NPC1 O15118 1/20 0.30
PLA2G1B P04054 1/20 0.30
HSP90AA1 P07900 1/20 0.30
MAPK1 P28482 1/20 0.30
HTT P42858 1/20 0.30
RAB9A P51151 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL4539581 0.88 MAPT (0.36) LMNANPSR1MAPTTP53THRB
SCHEMBL408787 0.86 MAPT (0.35) LMNANPSR1MAPTTP53THRB
Sulfuric Acid SCHEMBL15227677 0.86 MAPT (0.38) LMNANPSR1MAPTTP53THRB
Sulfuric Acid SCHEMBL1293162 0.84 MAPT (0.34) LMNANPSR1MAPTTP53THRB
SCHEMBL409129 0.82 MAPT (0.38) LMNANPSR1MAPTTP53THRB
SCHEMBL412540 0.82 MAPT (0.33) LMNANPSR1MAPTTP53THRB
SCHEMBL3451046 0.82 MAPK1 (0.31) NPSR1MAPTRECQLBLMMEN1
SCHEMBL29074312 0.81 MAPT (0.37) LMNANPSR1MAPTTP53THRB
SCHEMBL893621 0.80 MEN1 (0.32) NPSR1MAPTMEN1APAF1NPC1
Trifluoromethanesulfonic Acid SCHEMBL318315 0.79 KCNH2 (0.33) LMNANPSR1MAPTTP53THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 601 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026099153-A1 DEVICE CAPABLE OF BONDING AND DEBONDING ON DEMAND TESA SE (DE) 2026-05-15 WO claimed
EP-4703496-A1 ETCHING COMPOSITION COMPRISING AT LEAST ONE IONIC LIQUID AND AT LEAST ONE LACTAMIDE AND PROCESS FOR COATING PLASTIC SURFACES WITH METALS BY USING THE SAME BASF SE (DE) 2026-03-04 EP claimed
CN-119823109-A An electrochromic material electrochromic composition and electrochromic device 吉林大学 2025-04-15 CN claimed
CN-111117594-B Electrochromic material and electrochromic device based on dynamic metal-ligand complexation 吉林大学 2024-03-26 CN claimed
US-20230180758-A1 SUBSTITUTED PYRROLINE-2-ONES AND THEIR USE AS HERBICIDES BAYER AKTIENGESELLSCHAFT (DE) 2023-06-15 US claimed
EP-4157851-A1 SUBSTITUTED PYRROLINE-2-ONES AND THEIR USE AS HERBICIDES Bayer Aktiengesellschaft (DE) 2023-04-05 EP claimed
US-20230059463-A1 3-(2-BROMO-4-ALKYNYL-6-ALKOXYPHENYL)-SUBSTITUTED 5-SPIROCYCLOHEXYL-3-PYRROLIN-2-ONES AND THEIR USE AS HERBICIDES BAYER AKTIENGESELLSCHAFT (DE) 2023-02-23 US claimed
CN-115702157-A Substituted pyrrolin-2-ones and their use as herbicides 拜耳公司 2023-02-14 CN claimed
US-11567385-B2 Electrochromic device THE BOEING COMPANY (US) 2023-01-31 US claimed
WO-2023274869-A1 3-(4-ALKENYL-PHENYL)-3-PYRROLINO-2-ONES AND THEIR USE AS HERBICIDES BAYER AKTIENGESELLSCHAFT (DE) 2023-01-05 WO claimed
WO-2009007014-A1 WATER-SOLUBLE CONCENTRATES OF 3-(2-ALKOXY-4-CHLORO-6-ALKYLPHENYL)-SUBSTITUTED TETRAMATES AND THEIR CORRESPONDING ENOLS BAYER CROPSCIENCE AG (DE) 2009-01-15 WO claimed
WO-2008138551-A2 3-(2-ALKOXY-PHENYL)-SUBSTITUTED TETRAMATES BAYER CROPSCIENCE AG (DE) 2008-11-20 WO claimed
EP-1362572-B1 Use of at least one particular organic salt for cleansing and/or conditioning keratinous materials, use of a particular organic salt as conditioning agent for said materials and process for cosmetic treatment OREAL (FR) 2008-04-16 EP claimed
EP-1869061-A2 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY Combimatrix Corporation (US) 2007-12-26 EP claimed
EP-1805206-A2 ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE Combimatrix Corporation (US) 2007-07-11 EP claimed
US-20070034513-A1 Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array COMBIMATRIX CORPORATION 2007-02-15 US claimed
WO-2006105037-A2 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY COMBIMATRIX CORPORATION (US) 2006-10-05 WO claimed
WO-2006031814-A2 ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE COMBIMATRIX CORPORATION (US) 2006-03-23 WO claimed
US-20060054511-A1 Electrochemical deblocking using a hydrazine derivative CUSTOMARRAY, INC. 2006-03-16 US claimed
US-20040005286-A1 Organic salt conditioner, organic salt-containing composition, and uses thereof L'OREAL (FR) 2004-01-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040005286-A1 Organic salt conditioner, organic salt-containing composition, and uses thereof KRT18, HCN4, PRKDC LMNA 3326/4885NPSR1 4474/4885MAPT 1305/4885
US-20230180758-A1 SUBSTITUTED PYRROLINE-2-ONES AND THEIR USE AS HERBICIDES DDT, HPD, ALDH18A1 LMNA 4705/4885NPSR1 2357/4885MAPT 3443/4885
US-20230059463-A1 3-(2-BROMO-4-ALKYNYL-6-ALKOXYPHENYL)-SUBSTITUTED 5-SPIROCYCLOHEXYL-3-PYRROLIN-2-ONES AND THEIR USE AS HERBICIDES DDT, BROX, CBR3 LMNA 3871/4885NPSR1 3065/4885MAPT 4139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.